Seraxis Inc
Seraxis Inc, located in Germantown, MD, is a clinical-stage regenerative medicine company focused on developing cell replacement therapies for patients with Type 1 diabetes. Their technology aims to replace the missing islets in individuals suffering from this condition, with a commitment to delivering practical therapies efficiently.
The company actively seeks strategic partnerships to advance novel therapies and invites proposals for scientific collaborations and licensing opportunities globally. Supported by notable investors including Frazier Life Sciences, Polaris Partners, and Eli Lilly, Seraxis is dedicated to overcoming challenges in the field of insulin-dependent diabetes treatment.
Generated from the website
Also at this address
You might also like
Partial Data by Infogroup (c) 2024. All rights reserved.